Agios Pharmaceuticals | El Costo De Ventas



Cost Of Sales Cambio Fecha
AbbVie USD 4.4B 184M 2024-12
Agios Pharmaceuticals USD 1.26M 477K 2024-12
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
Amgen USD 3.11B 198M 2024-12
Astellas Pharma JPY 98.52B 15.83B 2024-12
AstraZeneca USD 2.72B 263M 2024-12
Bayer EUR 5.72B 633M 2024-12
Biogen USD 583.5M 55.2M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Daiichi Sankyo JPY 128.38B 30.35B 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Exelixis USD 19.96M 2.64M 2025-01
Gilead Sciences USD 1.58B 7M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
Incyte USD 82.38M 2.49M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
Merck USD 3.71B 181M 2024-12
Moderna USD 546M 246M 2024-12
Novartis USD 3.32B 90M 2024-12
Novartis USD 3.31B 73M 2024-12
Pfizer USD 5.65B 781M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Agios Pharmaceuticals El Costo De Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.